nach oben

Erschienen in:

22.06.2018 | Original Article

Redistribution of Mature Smooth Muscle Markers in Brain Arteries in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy

verfasst von: John R. Gatti, Xiaojie Zhang, Ejona Korcari, Soo Jung Lee, Nya Greenstone, Jon G. Dean, Snehaa Maripudi, Michael M. Wang

Erschienen in: Translational Stroke Research | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

Vascular smooth muscle cells (SMCs) undergo a series of dramatic changes in CADASIL, the most common inherited cause of vascular dementia and stroke. NOTCH3 protein accumulates and aggregates early in CADASIL, followed by loss of mature SMCs from the media of brain arteries and marked intimal proliferation. Similar intimal thickening is seen in peripheral arterial disease, which features pathological intimal cells including proliferative, dedifferentiated, smooth muscle-like cells deficient in SMC markers. Limited studies have been performed to investigate the differentiation state and location of SMCs in brain vascular disorders. Thus, we investigated the distribution of cells expressing SMC markers in a group of genetically characterized, North American CADASIL brains. We quantified brain RNA abundance of these markers in nine genetically verified cases of CADASIL and found that mRNA expression for several mature SMC markers was increased in CADASIL brain compared to age-matched control. Immunohistochemical studies and in situ hybridization localization of mRNA demonstrated loss of SMCs from the arterial media, and SMC marker-expressing cells were instead redistributed into the intima of diseased arteries and around balloon cells of the degenerating media. We conclude that, despite loss of medial smooth muscle cells in diseased arteries, smooth muscle markers are not lost from CADASIL brain, but rather, the localization of cells expressing mature SMC markers changes dramatically.

Miao Q, Paloneva T, Tuominen S, Pöyhönen M, Tuisku S, Viitanen M, et al. Fibrosis and stenosis of the long penetrating cerebral arteries: the cause of the white matter pathology in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Brain Pathol. 2004;14:358–64. https://doi.org/10.1111/j.1750-3639.2004.tb00078.x.CrossRefPubMed

Kalimo H, Viitanen M, Amberla K, et al. CADASIL: hereditary disease of arteries causing brain infarcts and dementia. Neuropathol Appl Neurobiol. 1999;25:257–65. https://doi.org/10.1046/j.1365-2990.1999.00198.x.CrossRefPubMed

Baudrimont M, Dubas F, Joutel A, Tournier-Lasserve E, Bousser M-G. Case report autosomal dominant leukoencephalopathy and subcortical ischemic stroke. Stroke. 1993;24:122–6.CrossRef

Joutel A, Vahedi K, Corpechot C, Troesch A, Chabriat H, Vayssière C, et al. Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients. Lancet. 1997;350:1511–5. https://doi.org/10.1016/S0140-6736(97)08083-5.CrossRefPubMed

Yamamoto Y, Craggs LJL, Watanabe A, Booth T, Attems J, Low RWC, et al. Brain microvascular accumulation and distribution of the NOTCH3 ectodomain and granular osmiophilic material in CADASIL. J Neuropathol Exp Neurol. 2013;72(5):416–31. https://doi.org/10.1097/NEN.0b013e31829020b5.CrossRefPubMed

Ruchoux MM, Domenga V, Brulin P, Maciazek J, Limol S, Tournier-Lasserve E, et al. Transgenic mice expressing mutant Notch3 develop vascular alterations characteristic of cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Am J Pathol. 2003;162(1):329–42. https://doi.org/10.1016/S0002-9440(10)63824-2.CrossRefPubMedPubMedCentral

Takahashi K, Adachi K, Yoshizaki K, Kunimoto S, Kalaria RN, Watanabe A. Mutations in NOTCH3 cause the formation and retention of aggregates in the endoplasmic reticulum, leading to impaired cell proliferation. Hum Mol Genet. 2009;19(1):79–89. https://doi.org/10.1093/hmg/ddp468.CrossRef

Dong H, Ding H, Young K, Blaivas M, Christensen PJ, Wang MM. Advanced intimal hyperplasia without luminal narrowing of leptomeningeal arteries in CADASIL. Stroke. 2013;44(5):1456–8. https://doi.org/10.3174/ajnr.A1650.Side.CrossRefPubMedPubMedCentral

Varcoe RL, Mikhail M, Guiffre AK, Pennings G, Vicaretti M, Hawthorne WJ. The role of the fibrocyte in intimal hyperplasia. J Thromb Haemost. 2006;4:1125–33.CrossRefPubMed

10.

Ruchoux M-M, Maurage C-A. CADASIL: cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. J Neuropathol Exp Neurol. 1997;56(9):947–64.CrossRefPubMed

11.

Gutierrez-Molina M, Caminero Rodriguez A, Martinez Garcia C, Arpa Gutierrez J, Morales Bastos C, Amer G. Small arterial granular degeneration in familial Binswanger’s syndrome. Acta Neuropathol. 1994;87:98–105.CrossRefPubMed

12.

Ruchoux M-M, Guerouaou D, Vandenhaute B, Pruvo J-P, Vermersch P, Leys D. Systemic vascular smooth muscle cell impairment in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Acta Neuropathol. 1995;89:500–12.CrossRefPubMed

13.

Skalli O, Ropraz P, Trzeciak A, Benzonana G, Gillessen D, Gabbiani G. A monoclonal antibody against alpha-smooth muscle actin: a new probe for smooth muscle differentiation. J Cell Biol. 1986;103(6 Pt 2):2787–96. https://doi.org/10.1083/jcb.103.6.2787.CrossRefPubMed

14.

Brennan-Krohn T, Salloway S, Correia S, Dong M, De La Monte SM. Glial vascular degeneration in CADASIL. J Alzheimers Dis. 2010;21(4):1393–402. https://doi.org/10.3233/JAD-2010-100036.CrossRefPubMedPubMedCentral

15.

Szpak GM, Lewandowska E, Wierzba-Bobrowicz T, et al. Small cerebral vessel disease in familial amyloid and non-amyloid angiopathies: FAD-PS-1 (P117L) mutation and CADASIL. Immunohistochemical and ultrastructural studies. Folia Neuropathol. 2007;45(4):192–204.PubMed

16.

Owens GK, Kumar MS, Wamhoff BR. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev. 2004;84:767–801. https://doi.org/10.1152/physrev.00041.2003.CrossRefPubMed

17.

Frid MG, Printesva OY, Chiavegato A, Faggin E, Scatena M, Koteliansky VE, et al. Myosin heavy-chain isoform composition and distribution in developing and adult human aortic smooth muscle. J Vasc Res. 1993;30:279–92.CrossRefPubMed

18.

Madsen CS, Regan CP, Hungerford JE, White SL, Manabe I, Owens GK. Smooth muscle specific expression of the smooth muscle myosin heavy chain gene in transgenic mice requires 5′-flanking and first intronic DNA sequence. Circ Res. 1998;82:908–17. https://doi.org/10.1161/01.RES.82.8.908.CrossRefPubMed

19.

Miano JM, Cserjesi P, Ligon KL, Periasamy M, Olson EN. Smooth muscle myosin heavy chain exclusively marks the smooth muscle lineage during mouse embryogenesis. Circ Res. 1994;75:803–12. https://doi.org/10.1161/01.RES.75.5.803.CrossRefPubMed

20.

van der Loop FT, Schaart G, Timmer ED, Ramaekers FC, van Eys GJ. Smoothelin, a novel cytoskeletal protein specific for smooth muscle cells. J Cell Biol. 1996;134(2):401–11.CrossRefPubMed

21.

Duband JL, Gimona M, Scatena M, Sartore S, Small JV. Calponin and SM22 as differentiation markers of smooth muscle: spatiotemporal distribution during avian embryonic development. Differentiation. 1993;55:1–11. https://doi.org/10.1111/j.1432-0436.1993.tb00027.x.CrossRefPubMed

22.

Gabbiani G, Schmid E, Winter S, Chaponnier C, de Ckhastonay C, Vandekerckhove J, et al. Vascular smooth muscle cells differ from other smooth muscle cells: predominance of vimentin filaments and a specific alpha-type actin. Proc Natl Acad Sci U S A. 1981;78(1):298–302. https://doi.org/10.1073/pnas.78.1.298.CrossRefPubMedPubMedCentral

23.

Owens GK, Thompson MM. Developmental changes in isoactin expression in rat aortic smooth muscle cells in vivo. Relationship between growth and cytodifferentiation. J Biol Chem. 1986;261(28):13373–80.PubMed

24.

Li L, Miano JM, Cserjesi P, Olson EN. SM22α, a marker of adult smooth muscle, is expressed in multiple myogenic lineages during embryogenesis. Circ Res. 1996;78(2):188 LP–195.CrossRef

25.

Han DKM, Liau G. Identification and characterization of developmentally regulated genes in vascular smooth muscle cells. Circ Res. 1992;71(3):711–9.CrossRefPubMed

26.

Owens GK. Regulation of differentiation of vascular smooth muscle cells. Physiol Rev. 1995;75(3):487–517.CrossRefPubMed

27.

Miano JM, Olson EN. Expression of the smooth muscle cell calponin gene marks the early cardiac and smooth muscle cell lineages during mouse embryogenesis [published erratum appears in J Biol Chem 1997 Oct 24;272(43):27492]. J Biol Chem. 1996;271(12):7095–103.CrossRefPubMed

28.

Zhang X, Lee SJ, Young MF, Wang MM. The small leucine-rich proteoglycan BGN accumulates in CADASIL and binds to NOTCH3. Transl Stroke Res. 2015;6(2):148–55. https://doi.org/10.1007/978-1-4939-2914-6.CrossRefPubMedPubMedCentral

29.

Zhang X, Lee SJ, Young KZ, Josephson DA, Michael D, Wang MM. Latent NOTCH3 epitopes unmasked in CADASIL and regulated by protein redox state. Brain Res. 2014;1583:230–6. https://doi.org/10.1016/j.brainres.2014.08.018.Latent.CrossRefPubMedPubMedCentral

30.

Shawber CJ, Kitajewski J. Notch function in the vasculature: insights from zebrafish, mouse and man. BioEssays. 2004;26(3):225–34. https://doi.org/10.1002/bies.20004.CrossRefPubMed

31.

Kalimo H, Ruchoux M-M, Viitanen M, Kalaria RN, et al. Brain Pathol. 2002;12:371–84. https://doi.org/10.1111/j.1750-3639.2002.tb00451.x.CrossRefPubMed

32.

Regan CP, Adam PJ, Madsen CS, Owens GK. Molecular mechanisms of decreased smooth muscle differentiation marker expression after vascular injury. J Clin Invest. 2000;106:1139–47.CrossRefPubMedPubMedCentral

33.

Aikawa M, Rabkin E, Voglic SJ, Shing H, Nagai R, Schoen FJ, et al. Muscle cells expressing smooth muscle myosin heavy. Circ Res. 1998;83(10):1015–26.CrossRefPubMed

34.

Yoon NK, Awad A-W, Kalani MYS, Taussky P, Park MS. Stent technology in ischemic stroke. Neurosurg Focus. 2017;42(4):1–9. https://doi.org/10.3171/2017.1.FOCUS16507.CrossRef

35.

Rensen SSM, Doevendans PAFM, van Eys GJJM. Regulation and characteristics of vascular smooth muscle cell phenotypic diversity. Netherlands Hear J. 2007;15:100–8. https://doi.org/10.1007/BF03085963.CrossRef

36.

Hao H, Gabbiani G, Bochaton-Piallat ML. Arterial smooth muscle cell heterogeneity: implications for atherosclerosis and restenosis development. Arterioscler Thromb Vasc Biol. 2003;23:1510–20. https://doi.org/10.1161/01.ATV.0000090130.85752.ED.CrossRefPubMed

37.

Beamish JA, He P, Kottke-Marchant K, Marchant RE. Molecular regulation of contractile smooth muscle cell phenotype: implications for vascular tissue engineering. Tissue Eng Part B Rev. 2010;16(5):467–91. https://doi.org/10.1089/ten.teb.2009.0630.CrossRefPubMedPubMedCentral

38.

Zhang X, Meng H, Blaivas M, Rushing EJ, Moore BE, Schwartz J, et al. von Willebrand factor permeates small vessels in CADASIL and inhibits smooth muscle gene expression. Transl Stroke Res. 2012;3(1):138–45. https://doi.org/10.1007/s12975-011-0112-2.Von. CrossRefPubMed

39.

Tikka S, Ng YP, Di MG, et al. CADASIL mutations and shRNA silencing of NOTCH3 affect actin organization in cultured vascular smooth muscle cells. J Cereb Blood Flow Metab. 2013;32:2171–80. https://doi.org/10.1038/jcbfm.2012.123. CrossRef

40.

Borgers M, Schaper J, Schaper W. The origin of subendothelial cells in developing coronary collaterals. Virchows Arch Abt A Path Anat. 1973;358:281–94.CrossRef

41.

Imai H, Lee KJ, Lee SK, Lett KT, O’Neal RM, Thomas WA. Ultrastructural features of aortic cells in mitosis in control and cholesterol-fed swine. Lab Investig. 1970;23:401–15.PubMed

42.

Yang P, Hong MS, Fu C, Schmit BM, Su Y, Berceli SA, et al. Pre-existing smooth muscle cells contribute to neointimal cell repopulation at an incidence varying widely among individual lesions. Surgery. 2016;159(2):602–12. https://doi.org/10.1021/acsnano.5b07425.Molecular.CrossRefPubMed

43.

Herring B, Hoggatt AM, Burlak C, Offermanns S. Previously differentiated medial vascular smooth muscle cells contribute to neointima formation following vascular injury. Vasc Cell. 2014;6:21. https://doi.org/10.1186/2045-824X-6-21.CrossRefPubMedPubMedCentral

44.

Chamley-Campbell J, Campbell GR, Ross R. The smooth muscle cell in culture. Physiol Rev. 1979;59(1):1–61.CrossRefPubMed

45.

Sata M, Saiura A, Kunisato A, Tojo A, Okada S, Tokuhisa T, et al. Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis. Nat Med. 2002;8(4):403–9. https://doi.org/10.1038/nm0402-403.CrossRefPubMed

46.

Tanaka K, Sata M, Hirata Y, Nagai R. Diverse contribution of bone marrow cells to neointimal hyperplasia after mechanical vascular injuries. Circ Res. 2003;93(8):783–90. https://doi.org/10.1161/01.RES.0000096651.13001.B4.CrossRefPubMed

47.

Tang Z, Wang A, Yuan F, Yan Z, Liu B, Chu JS, et al. Differentiation of multipotent vascular stem cells contributes to vascular diseases. Nat Commun. 2012;3(875):875. https://doi.org/10.1038/ncomms1867.CrossRefPubMedPubMedCentral

48.

Hao H, Ropraz P, Verin V, et al. Heterogeneity of smooth muscle cell populations cultured from pig coronary artery. Atheroscler Thromb Vasc Biol. 2002;22:1093–9. https://doi.org/10.1161/01.ATV.0000022407.91111.E4.CrossRef

49.

Lee SJ, Zhang X, Wang MM. Vascular accumulation of the small leucine rich proteoglycan decorin in CADASIL. Neuroreport. 2014;25(13):1059–63. https://doi.org/10.1097/WNR.0000000000000230.Vascular. CrossRefPubMedPubMedCentral

50.

51.

Dong H, Blaivas M, Wang MM. Bidirectional encroachment of collagen into the tunica media in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Brain Res. 2012;1456:64–71. https://doi.org/10.1038/jid.2014.371. CrossRefPubMedPubMedCentral

Titel: Redistribution of Mature Smooth Muscle Markers in Brain Arteries in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy
verfasst von: John R. Gatti
Xiaojie Zhang
Ejona Korcari
Soo Jung Lee
Nya Greenstone
Jon G. Dean
Snehaa Maripudi
Michael M. Wang
Publikationsdatum: 22.06.2018
Verlag: Springer US
Erschienen in: Translational Stroke Research / Ausgabe 2/2019
Print ISSN: 1868-4483
Elektronische ISSN: 1868-601X
DOI: https://doi.org/10.1007/s12975-018-0643-x

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Akuter Schwindel: Wann lohnt sich eine MRT?

28.04.2024 Schwindel Nachrichten

Akuter Schwindel stellt oft eine diagnostische Herausforderung dar. Wie nützlich dabei eine MRT ist, hat eine Studie aus Finnland untersucht. Immerhin einer von sechs Patienten wurde mit akutem ischämischem Schlaganfall diagnostiziert.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2019

Mitochondrial Dysfunction in Stroke: Implications of Stem Cell Therapy

Intrathecal Injection of Allogenic Bone Marrow-Derived Mesenchymal Stromal Cells in Treatment of Patients with Severe Ischemic Stroke: Study Protocol for a Randomized Controlled Observer-Blinded Trial

Enriched Environment Elicits Proangiogenic Mechanisms After Focal Cerebral Ischemia

Radiologic Cerebral Reperfusion at 24 h Predicts Good Clinical Outcome

Post-stroke Recrudescence from Infection: an Immunologic Mechanism?